GH Live signaler | Maksimer profitt med Getagraph.com

KJøP 101823 min ago

@ $22.28

Utstedt: 14 feb 2024 @ 19:20

Avkastning: -18.76%

Forrige signal: feb 14 - 15:30

Forrige signal: Selg

Avkastning: 1.83 %

Live Chart Being Loaded With Signals

Commentary (24 apr 2024 @ 22:00):

Stats
Dagens volum	1.58M
Gjennomsnittsvolum	1.98M
Markedsverdi	2.20B
EPS	$0 ( 2024-02-22 )
Neste inntjeningsdato	( $-0.940 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.23
ATR14	$0.0250 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Tariq Musa	Sell	249	Restricted Stock Units
2024-04-15	Tariq Musa	Buy	249	Common Stock
2024-04-15	Saia John G.	Buy	7 569	Common Stock
2024-04-15	Saia John G.	Sell	2 701	Common Stock
2024-04-15	Saia John G.	Sell	1 108	Common Stock

INSIDER POWER
-46.43
Last 99 transactions
Buy: 864 284 \| Sell: 2 349 747

Volum Korrelasjon

Lang: 0.39 (neutral)

Kort: 0.95 (very strong)

Signal:(64.247) Expect same movement, but be aware

Guardant Health Inc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Guardant Health Inc Korrelasjon - Valuta/Råvare

0.56
( weak )

0.06
( neutral )

0.00
( neutral )

0.31
( neutral )

0.70
( moderate )

0.05
( neutral )

Guardant Health Inc Økonomi

Annual	2023
Omsetning:	$563.95M
Bruttogevinst:	$336.90M (59.74 %)
EPS:	$-4.28

Q4	2023
Omsetning:	$155.05M
Bruttogevinst:	$236.19M (152.33 %)
EPS:	$-1.580

Q3	2023
Omsetning:	$143.03M
Bruttogevinst:	$85.42M (59.72 %)
EPS:	$-0.730

Q2	2023
Omsetning:	$137.15M
Bruttogevinst:	$83.30M (60.74 %)
EPS:	$-0.670

Financial Reports:

No articles found.

Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.